Business Services

Altimmune

$14.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 2:40 PM UTC today

Why Robinhood?

You can buy or sell Altimmune and other stocks, options, and ETFs commission-free!

About ALT

Altimmune, Inc. Common Stock, also called Altimmune, is a clinical stage immunotherapeutic biotechnology company. It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is headquartered in Gaithersburg, MD. The listed name for ALT is Altimmune, Inc. Common Stock.

CEO
Vipin K. Garg
Employees
25
Headquarters
Gaithersburg, Maryland
Founded
1997
Market Cap
502.95M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.39M
High Today
$15.15
Low Today
$14.70
Open Price
$14.80
Volume
237.49K
52 Week High
$35.10
52 Week Low
$1.60

Collections

ALT Earnings

-$0.94
-$0.63
-$0.31
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 26, After Hours

You May Also Like

AWAY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure